The platelet volume in patients with cardiac syndrome X by Varol, Ercan et al.
The platelet volume in patients with cardiac syn-
drome X
Ercan Varol, Mehmet Ozaydin, Abdullah Dogan, Dogan Erdogan
Suleyman Demirel University Isparta, Faculty of Medicine, Department of Cardiology, Isparta, Turkey.
Email: drercanvarol@yahoo.com
Tel.: +90 5323468258
Demirkol et al. (1) compared the mean platelet volume
(MPV) in the plasma of patients with cardiac syndrome X,
patients with coronary artery disease and healthy controls.
They observed that the MPV in patients with cardiac
syndrome X and coronary artery disease was significantly
higher than that observed in the control group. There were
no significant differences in the MPV between the cardiac
syndrome X and the coronary artery disease groups.
Although this study is interesting, we would like to make
a minor criticism based on its methodological aspects.
Blood was collected in a Vacutainer tube containing
ethylenediaminetetraacetic acid (EDTA) to measure the
MPV. The authors analyzed the blood samples after two
hours of venipuncture. However, a two-hour delay after
blood sampling can cause abnormal MPV measurement
results. This abnormality is important in tubes containing
EDTA. As we know, platelets exhibit a time-dependent
swelling when blood samples are anticoagulated with EDTA;
however, this swelling does not occur in the presence of
citrate (2). With impedance counting, the MPV increases over
time as the platelets swell in EDTA. An increase of 7.9%
within 30 min and an overall increase of 13.4% over 24 hours
have been reported, although the majority of this increase
occurs within the first 6 hours (3). The recommended optimal
measuring time for MPV is 120 min after venipuncture (4).
For reliable MPV measurements, the potential influence of
the anticoagulant must be carefully controlled either by using
an alternative anticoagulant, such as citrate, or by standar-
dizing the time delay between sampling and analysis (less
than 2 hours).
The pathophysiology of cardiac syndrome X is still being
debated; however, endothelial dysfunction leading to a
reduced coronary microvascular dilatory response and
increased coronary resistance are thought to play important
roles. We wish to add our experience with respect to this
subject. In our previous study, we investigated whether
MPV increased in patients with idiopathic dilated cardio-
myopathy and whether increased MPV correlated with the
degree of coronary microvascular dysfunction (5). We have
found that MPV is an independent predictor of lower
coronary flow reserve. Therefore, we believe that impaired
coronary microvascular function as a result of endothelial
dysfunction plays an important role in increasing the MPV.
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